Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer.
about
A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination.Dendritic cells fused with different pancreatic carcinoma cells induce different T-cell responsesPancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?
P2860
Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Investigation of a new tumor-a ...... cination in pancreatic cancer.
@en
type
label
Investigation of a new tumor-a ...... cination in pancreatic cancer.
@en
prefLabel
Investigation of a new tumor-a ...... cination in pancreatic cancer.
@en
P2093
P2860
P356
P1433
P1476
Investigation of a new tumor-a ...... cination in pancreatic cancer.
@en
P2093
Aurélie Collignon
Cécile Franceschi
Daniel Olive
Dominique Lombardo
Evelyne Béraud
P2860
P356
10.4161/ONCI.1.1.18459
P577
2012-01-01T00:00:00Z